Two separate studies reported that IFN-γ from ICIs-activated CD8 + T cells sensitized tumor cells to ferroptosis, implying that targeting ferroptotic pathways constitutes a tumor therapeutic approach when combined with ICIs [8, 18]. This evidence concerns the gene CD8A and neoplasm.